These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28406088)

  • 1. Population pharmacokinetics of vancomycin in Chinese infants
.
    Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
    Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
    BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
    Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
    Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
    Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
    Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
    Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Population pharmacokinetics of vancomycin from severe in patients with lower respiratory tract infection].
    Yang W; He B; Deng CH
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):205-209. PubMed ID: 28297816
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections.
    Zhou Y; Gao F; Chen C; Ma L; Yang T; Liu X; Liu Y; Wang X; Zhao X; Que C; Li S; Lv J; Cui Y; Yang L
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):361-370. PubMed ID: 30506225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
    Marqués-Miñana MR; Saadeddin A; Peris JE
    Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
    Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
    Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
    Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
    J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
    Chu Y; Luo Y; Ji S; Jiang M; Zhou B
    J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
    Moffett BS; Morris J; Galati M; Munoz F; Arikan AA
    Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the age dependency of vancomycin clearance by population pharmacokinetic modeling.
    Usman M; Fobker M; Hempel G
    Int J Clin Pharmacol Ther; 2018 Feb; 56(2):56-63. PubMed ID: 29319495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.